State of Wisconsin Investment Board
NVLN

State of Wisconsin Investment Board’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

State of Wisconsin Investment Board’s Portfolio NVLN Stock Details NVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-11,000
Closed -$38K – 1524
2018
Q1 		$38K Hold
11,000
– – ﹤0.01% 1450
2017
Q4 		$34K Hold
11,000
– – ﹤0.01% 1444
2017
Q3 		$77K Hold
11,000
– – ﹤0.01% 1445
2017
Q2 		$102K Buy
+11,000
New +$106K ﹤0.01% 1445

Other funds holding NVLN

EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

State of Wisconsin Investment Board's NVLN Position: Q2 2018 in Review

State of Wisconsin Investment Board sold out of Novelion Therapeutics Inc. Common Shares (NVLN) in Q2 2018, closing a stake of 11,000 shares — an estimated $38K sold.

State of Wisconsin Investment Board first reported a position in NVLN in Q2 2017 and held it in 4 quarters. The position peaked at $102K in Q2 2017. 53 funds tracked by Wall St. Rank hold NVLN as of Q2 2018.

  • State of Wisconsin Investment Board reported no remaining Novelion Therapeutics Inc. Common Shares position as of Q2 2018 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 11,000 Novelion Therapeutics Inc. Common Shares shares in Q2 2018, an estimated $38K.
  • State of Wisconsin Investment Board first reported a position in Novelion Therapeutics Inc. Common Shares in Q2 2017 and held it in 4 quarters.
  • State of Wisconsin Investment Board's Novelion Therapeutics Inc. Common Shares position peaked at $102K in Q2 2017.
  • 53 funds tracked by Wall St. Rank held Novelion Therapeutics Inc. Common Shares as of Q2 2018.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2018, filed 3 Aug 2018.